VILLANOVA DI SAN DANIELE DEL FRIULI, Udine, Italy, Sept. 12, 2022 /PRNewswire/ — LimaCorporate, a number one world orthopedic producer targeted on digital innovation and patient-tailored units, immediately proclaims that Massimo Calafiore has been appointed by the Board of Directors as the brand new Chief Executive Officer of the corporate. Massimo’s appointment follows an intensive choice course of that thought-about each inner and exterior candidates. Emmanuel Bonhomme, who has led the group over the past 5 months as interim CEO, will tackle the newly created function of Chief Commercial Officer.
Massimo has just lately served as Executive Vice President and Chief Commercial Officer of NuVasive, a world chief in orthopedic backbone expertise. Before that, he was liable for the Company’s Product Marketing and Commercial Functions, in addition to the Company’s Business Units, NuVasive Specialized Orthopedics, and NuVasive Clinical Services. With greater than 20 years of expertise within the orthopedic subject and in depth data of the worldwide orthopedic markets, he’ll lead the group’s patient-centric focus and continued funding in innovation and business development.
Lars Rasmussen, Chairperson of the LimaCorporate Advisory Board, commented: “We strongly believe that Massimo is the right person to lead this new phase of our business. He brings extensive industry experience, excellent strategic and leadership skills and a track record of values-based leadership focused on improving patients’ lives. I would like to thank Emmanuel Bonhomme for his dedication as interim CEO and congratulate him on his new role as Chief Commercial Officer.”
Emmanuel Bonhomme commented: “It has been a pleasure and an honor to lead LimaCorporate during the last five months as interim CEO and I am very excited to carry on serving our surgeons around the world in my new role. I welcome Massimo as our new CEO and I am committed to supporting him and the Company to continue to enhance LimaCorporate’s position in the industry, offering the best and most advanced solutions for our surgeons and patients.”
Massimo Calafiore remarked: “I’m honored to tackle this function as CEO of LimaCorporate. Thanks to our inner expertise, know-how, and industry-leading R&D capabilities, I’ll proceed to concentrate on positioning the corporate as a world chief in superior orthopedic options. I look forwards to working carefully with all the staff and the Leadership Team to proceed to serve our surgeons and sufferers across the globe, as we rework orthopedics, advance affected person care, and most significantly, restore the eMotion of Motion in all of our sufferers.
“I also would like to thank Emmanuel for the passion, energy, and enthusiasm he demonstrated in leading LimaCorporate as interim CEO and the Board of Directors for giving me the opportunity to lead the organization during this new phase of growth, helping patients around the world with our innovative products.”
About LimaCorporate
LimaCorporate is a world orthopedic firm, targeted on digital innovation and patient-tailored {hardware}, which advances patient-centred care. Its pioneering technological options are developed to empower surgeons, and to enhance affected person outcomes from joint substitute surgical procedure. Its major focus is on offering reconstructive and custom-made orthopedic options to surgeons, enabling them to enhance the standard of lifetime of sufferers by restoring the enjoyment of motion.
Headquartered in Italy, the corporate operates straight in over 20 nations world wide. LimaCorporate provides merchandise starting from massive joint revision and first implants, to finish extremities options, together with fixation.
For further info on the Company, please go to www.limacorporate.com
Limacorporate spa
Via Nazionale, 52
33038 Villanova di San Daniele
Udine – Italy
t: +39 0432 945511
e.: [email protected]
